Thorne Healthtech, Inc. Common Stock
THRN
THRN was delisted on the 13th of October, 2023.
41 hedge funds and large institutions have $54.1M invested in Thorne Healthtech, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 41 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$9.17M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$6.11M |
| 3 |
Millennium Management
New York
|
+$4.02M |
| 4 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
+$3.74M |
| 5 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
+$3.61M |
Top Sellers
THRN Hedge Fund Activity: Q3 2021 in Review
41 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Thorne Healthtech, Inc. Common Stock (THRN) for Q3 2021, worth a combined $54.1M.
Buyers outnumbered sellers: 41 funds opened new THRN positions and 0 closed out — a net gain of 41 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Driehaus Capital Management, opening a new position worth an estimated $9.17M.
- 41 institutional investors held Thorne Healthtech, Inc. Common Stock (THRN) as of Q3 2021, up from 0 in Q2 2021.
- Funds reported $54.1M of Thorne Healthtech, Inc. Common Stock stock for Q3 2021.
- 41 funds opened new Thorne Healthtech, Inc. Common Stock positions in Q3 2021 and 0 closed out, a net change of +41 holders.
- The largest Thorne Healthtech, Inc. Common Stock buyer in Q3 2021 was Driehaus Capital Management, an estimated $9.17M added.
Based on aggregated 13F filings for Q3 2021.